2nd Annual TGF-β for Immuno-Oncology Drug Development

Tuesday, January 25th – Thursday, January 27th

Digital Event:
Click here for access

Overview:

Outcome’s Dr. John Armstrong will be providing An Overview of the TGF-β IO Market including:

Current approaches in the TGF-β IO market
Recent M&A, equity financing, and strategic partnership transactions in the TGF- β IO market
How to position your company, team, and asset for a successful entry into the TGF-β IO market

For more information, please contact jarmstrong@outcomecapital.com

Appointment of Charles Simmons as Managing Director continues to strengthen Outcome’s capabilities

Outcome Capital Life Science Market Pulse November 2024 Click to view our LifeSciences Pulse Newsletter

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?